Al HaYaT Medicos

Articles › Endocrinology

Type 2 Diabetes: Diagnosis, Medicines and Complications

By the Al HaYaT Medicos team · 3 min read

Type 2 diabetes mellitus is a chronic metabolic disease caused by insulin resistance together with a progressive decline in insulin secretion. It is extremely common in South Asia, often develops at a younger age and lower body weight than in Western populations, and is a leading cause of heart disease, kidney failure, blindness and amputation.

Risk factors

Clinical features

Many patients have no symptoms and are found on screening. Classic symptoms include:

Some patients first present with a complication.

Diagnosis (WHO / ADA thresholds)

In someone without symptoms, an abnormal result should be confirmed with a repeat test. HbA1c is unreliable in some conditions, for example haemoglobinopathies such as thalassaemia trait, recent blood loss or transfusion, pregnancy and advanced kidney disease.

Management

Lifestyle

Medicines

HbA1c targets are individualised. Around 53 mmol/mol (7%) is common, with lower or higher targets depending on the patient's age, hypoglycaemia risk and other conditions.

Cardiovascular risk reduction

Complications and annual review

The annual review should cover:

Exam pearls

For a complete diabetes chapter, see the endocrinology part of our Medicine Companion. See also Diabetic Ketoacidosis.

Test yourself

5 exam-style single-best-answer questions. Choose your answer, then tap “Show answer”.

  1. Which HbA1c value is diagnostic of diabetes?

    1. 42 mmol/mol (6.0%)
    2. 38 mmol/mol (5.6%)
    3. 45 mmol/mol (6.3%)
    4. Any value above 40
    5. 48 mmol/mol (6.5%) or higher
    Show answer

    Answer: E. 48 mmol/mol (6.5%) or higher
    HbA1c ≥48 mmol/mol (6.5%) is diagnostic; confirm with a repeat test if no symptoms.

  2. Type 2 diabetes with established heart failure. Which drug class is especially recommended?

    1. Pioglitazone
    2. Meglitinide
    3. SGLT2 inhibitor
    4. Sulfonylurea
    5. DPP-4 inhibitor
    Show answer

    Answer: C. SGLT2 inhibitor
    SGLT2 inhibitors reduce heart failure hospitalisation and protect the kidneys.

  3. Why may HbA1c be unreliable in a patient with thalassaemia trait?

    1. HbA1c is only for children
    2. It measures insulin
    3. It is always accurate
    4. Haemoglobinopathies alter HbA1c measurement and red cell lifespan
    5. Thalassaemia raises glucose
    Show answer

    Answer: D. Haemoglobinopathies alter HbA1c measurement and red cell lifespan
    Haemoglobin variants, recent blood loss, transfusion and pregnancy affect HbA1c.

  4. Which side effect is typical of sulfonylureas?

    1. Hypoglycaemia
    2. Genital infections
    3. Pancreatitis only
    4. Weight loss
    5. Lactic acidosis
    Show answer

    Answer: A. Hypoglycaemia
    Sulfonylureas stimulate insulin release and cause hypoglycaemia and weight gain.

  5. Which is part of the annual diabetes review?

    1. Chest CT
    2. Retinal screening and foot examination
    3. Lumbar puncture
    4. Colonoscopy
    5. Bone marrow biopsy
    Show answer

    Answer: B. Retinal screening and foot examination
    Annual review includes HbA1c, BP, lipids, kidney tests, retinal screening and foot checks.

More articles in Endocrinology

Browse all 56 articles →

Disclaimer

For education and exam preparation only. This is not medical advice and must not be used to diagnose or treat patients. Always follow current clinical guidelines and the advice of qualified senior colleagues.

Spotted a mistake? Help us keep this page accurate.